• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    ATEC to Preview the Informatics Sophistication of EOS Catalyst™ at NASS 2023

    10/17/23 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care
    Get the next $ATEC alert in real time by email

    Enhances EOS platform with automated alignment, surgical planning, patient-specific rod-bending, and intra-operative alignment reconciliation capabilities

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that EOS Catalyst will be introduced at the 2023 NASS Annual Meeting. EOS Catalyst builds on the already unprecedented functionality of the EOS imaging platform with automated alignment and surgical planning capabilities.

    "EOS is foundational to ATEC's mission to revolutionize spine surgery," said Pat Miles, Chairman and Chief Executive Officer. "Catalyst will be the first reflection of our influence on EOS' technological prowess, accelerating the informatics sophistication of the platform with capabilities that will objectively improve the predictability and reproducibility of spine care, from straightforward surgery to complex deformity, including adolescent idiopathic scoliosis treatment. We're excited to fully release Catalyst in 2024 and champion a step forward for spine – no other platform will be able to replicate EOS' influence on patient care."

    Dr. Vedat Deviren, MD, Spine Surgeon and Professor of Orthopaedic Surgery at the UCSF Medical Center, added, "EOS imaging is a requirement for successful outcomes in both long and short-segment spine surgery, which is why I have relied on its high-quality images and alignment information in my surgical planning process for three years. I can't wait to incorporate the groundbreaking workflow efficiencies and clinical predictability that EOS Catalyst will make possible. I will be able to enter surgery with an informed template and customized rods, then intra-operatively reconcile to plan. Ultimately, the data collection that is underway will found our industry's first predictive care capabilities. The end-to-end solutions offered by EOS Catalyst will become the standard of care."

    About EOS Catalyst

    EOS Catalyst integrates information and data collection throughout the surgical experience through a cloud-based platform. The initial Catalyst release will include the following:

    • Automatic, quantified alignment assessment. AI-driven alignment information with level-labeling and color-coded patient benchmarking to normative values will be available minutes after an EOS exam.
    • 3D-surgical planning. 3D-modelling of the patient's spine and alignment will more easily designate patients for surgery.
    • Patient-specific pre-bent rods. Seamless ordering, approval and delivery of pre-bent rods for short and long construct surgery will improve intra-operative sagittal correction.
    • Intra-operative reconciliation. Full-spine intra-operative measurements of key coronal and sagittal parameters throughout surgery will inform objective comparisons to the pre-operative plan and enable exportation for post-operative analysis.

    The Company expects the Catalyst platform, which is currently under limited evaluation, to be released in mid-2024.

    Innovation Update for Investors

    The EOS Catalyst Platform will be a feature of the technology-focused meeting for investors on October 18, 2023, from 7:30am to 9:00am PT at the JW Marriott Los Angeles. RSVP here if you plan to join the event in person. A webcast will be also available for those unable to attend. To access the webcast, please visit the Investor Relations Section of ATEC's Corporate Website.

    Booth Presentations

    ATEC is partnering with renowned spine surgeons to demonstrate how ATEC innovation can improve clinical precision and predictability. Visit ATEC booth #1801 to view the following presentations:

    Presentation

    Date

    Time (PT)

    Presenter

    PTP™: The Evolution of the Lateral Approach

    10/18

    9:10am

    Luiz Pimenta, MD, PhD

    William Taylor, MD

    Informing Better Spine Surgery with Precision Technology

    10/18

    12:00pm

    Juan Uribe, MD

    Kevin Foley, MD

    Streamlined Single Position Anterior Column Approaches

    10/18

    3:00pm

    Hardeep Singh, MD

    EOS: Standardizing Care with End-To-End Solutions

    10/19

    9:35am

    Vedat Deviren, MD

    Achieving Sagittal Alignment with PTP™ and Calibrate™ LTX

    10/19

    12:00pm

    Vedat Deviren, MD

    Srikanth N. Divi, MD

    Reducing Mechanical Complications in Adult Spinal Deformity: Invictus® Fenestrated and S.I. Core

    10/19

    3:00pm

    Jay Turner, MD

    About ATEC

    ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC's Organic Innovation Machine™ is focused on developing new approaches that integrate seamlessly with the Company's expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC's vision is to be the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.

    Forward Looking Statements

    This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described therein. Forward-looking statements include references to the Company's expectations with respect to future revenue and growth and planned commercial launches, introductions, integration, regulatory submissions or clearances. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: failure to achieve acceptance of the Company's products by the surgeon community and the uncertainty of success in developing new products or products currently in the pipeline. The words "believe," "will," "should," "expect," "intend," "estimate," "look forward" and "anticipate," and variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. A further list and description of these and other factors, risks and uncertainties can be found in the Company's most recent annual report, and any subsequent quarterly and current reports, filed with the Securities and Exchange Commission. ATEC disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231017107998/en/

    Get the next $ATEC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEC

    DatePrice TargetRatingAnalyst
    6/16/2025$18.00Buy
    Lake Street
    8/1/2024Overweight → Equal-Weight
    Morgan Stanley
    7/8/2024$19.00Overweight
    Barclays
    2/9/2024$26.00Overweight
    Wells Fargo
    12/19/2023$16.00 → $18.00Buy
    Needham
    10/20/2023$22.00Buy
    ROTH MKM
    10/12/2022$12.00Buy
    Jefferies
    9/12/2022$13.00Overweight
    Morgan Stanley
    More analyst ratings

    $ATEC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF OPERATING OFFICER Lish Scott sold $148,832 worth of shares (9,302 units at $16.00), decreasing direct ownership by 1% to 665,030 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/15/25 5:42:21 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CEO Miles Patrick gifted 10,000 shares, decreasing direct ownership by 0.17% to 5,864,078 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/14/25 6:20:24 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    EVP, SALES Sponsel David covered exercise/tax liability with 982 shares, decreasing direct ownership by 0.15% to 671,861 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/7/25 7:04:15 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ATEC to Participate in Upcoming Conferences

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025. The RBCCM Medical Supplies & Devices Virtual Symposium virtually on August 18, 2025, from 10:00am – 11:00am ET. The Piper Sandler MedTech and Diagnostics West Coast Bus Tour at The Ritz Carlton Laguna Niguel in Dana Point, CA at 7:55am PT. The Wells Fargo 2025 Healthcare Conference beginning on September 3, 2025, at The Encore Boston Harbor in Everett, MA, with a fireside c

    8/8/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance

    Surgical revenue grew 29% to $168 million Total revenue grew $40 million or 27.5% Full-year revenue and profitability guidance increased Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2025, and recent corporate highlights. Second Quarter 2025 Financial Results   Quarter Ended June 30, 2025 Total revenue $186 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $142 million Non-GAAP operating expenses $122 milli

    7/31/25 4:05:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

    7/17/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:32:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:27:25 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Demski David M bought $283,500 worth of shares (50,000 units at $5.67), increasing direct ownership by 21% to 288,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/21/24 10:00:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    SEC Filings

    View All

    SEC Form 144 filed by Alphatec Holdings Inc.

    144 - Alphatec Holdings, Inc. (0001350653) (Subject)

    8/4/25 4:22:30 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Alphatec Holdings Inc.

    10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)

    7/31/25 4:51:35 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Alphatec Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    7/31/25 4:19:03 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Leadership Updates

    Live Leadership Updates

    View All

    Paragon 28 Appoints Dave Demski to Board of Directors

    Paragon 28, Inc. (NYSE:FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities. Mr. Demski most recently served as the President and CEO of Globus Medical from August 2017 to April 2022, guiding the organization through a period of signifi

    12/11/24 9:00:00 AM ET
    $ATEC
    $FNA
    Medical/Dental Instruments
    Health Care

    Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new terri

    4/4/24 9:05:00 AM ET
    $ATEC
    $SYK
    Medical/Dental Instruments
    Health Care

    John Booth to Retire as CEO of Spineology Inc.

    Brian Snider Appointed New CEO Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today that John Booth will retire from his role as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as its next Chief Executive Officer, effective November 13, 2023. Mr. Booth will remain with Spineology through 2024, serving in an advisory role to facilitate a smooth transition. Mr. Booth will also resign from the Board of Directors, and the Board has nominated Mr. Snider as a Director. Snider joins Spineology with nearly twenty years of progressive leadership experience in the

    11/9/23 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Financials

    Live finance-specific insights

    View All

    ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

    7/17/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report First Quarter 2025 Financial Results on May 1, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2025 financial results on May 1, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Inducemen

    4/14/25 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Third Quarter Financial Results on October 30, 2024

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Indu

    10/7/24 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on Alphatec with a new price target

    Lake Street resumed coverage of Alphatec with a rating of Buy and set a new price target of $18.00

    6/16/25 8:53:19 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Alphatec downgraded by Morgan Stanley

    Morgan Stanley downgraded Alphatec from Overweight to Equal-Weight

    8/1/24 3:06:35 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Barclays initiated coverage on Alphatec with a new price target

    Barclays initiated coverage of Alphatec with a rating of Overweight and set a new price target of $19.00

    7/8/24 7:34:11 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/12/24 8:04:57 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    3/22/24 7:57:56 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    5/12/23 4:51:18 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care